Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Head and Neck Cancer

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 139 articles:
HTML format



Single Articles


    March 2024
  1. AIOLFI A, Bona D, Bonitta G, Bonavina L, et al
    Short-term Outcomes of Different Techniques for Gastric Ischemic Preconditioning Before Esophagectomy: A Network Meta-analysis.
    Ann Surg. 2024;279:410-418.
    PubMed     Abstract available


    January 2024
  2. PARK SY, Park B, Yun JK, Kim HR, et al
    Proposal of New ypStage Grouping System for Esophageal Squamous Cell Carcinoma Patients who Underwent Neoadjuvant Chemoradiotherapy followed by Surgery.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006204.
    PubMed     Abstract available


    December 2023
  3. KARALIS JD, Ju MR, Yoon LY, Castro-Dubon EC, et al
    Serum Interleukin 6 Level is Associated With Overall Survival and Treatment Response in Gastric and Gastroesophageal Junction Cancer.
    Ann Surg. 2023;278:918-924.
    PubMed     Abstract available


  4. OWEN RP, Chidambaram S, Griffiths EA, Sultan J, et al
    Multicenter, Prospective Cohort Study of Oesophageal Injuries and Related Clinical Outcomes (MUSOIC study).
    Ann Surg. 2023;278:910-917.
    PubMed     Abstract available


    November 2023
  5. WIRSIK NM, Schmidt T, Nienhuser H, Donlon NE, et al
    Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2023;278:683-691.
    PubMed     Abstract available


  6. VEZIANT J, Boudis F, Lenne X, Bruandet A, et al
    Outcomes Associated With Esophageal Perforation Management: Results From a French Nationwide Population-based Cohort Study.
    Ann Surg. 2023;278:709-716.
    PubMed     Abstract available


  7. ELLIOTT JA, Klevebro F, Mantziari S, Markar SR, et al
    Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
    Ann Surg. 2023;278:692-700.
    PubMed     Abstract available


  8. HWANG H, Choi JY, Yu HW, Moon JH, et al
    Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
    Ann Surg. 2023;278:e1087-e1095.
    PubMed     Abstract available


    September 2023
  9. COWZER D, Wu AJ, Sihag S, Walch HS, et al
    Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.
    Ann Surg. 2023;278:e511-e518.
    PubMed     Abstract available


    July 2023
  10. CHIDAMBARAM S, Owen R, Sgromo B, Chmura M, et al
    Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006028.
    PubMed     Abstract available


  11. ALTORKI N, Mynard N, Nasar A, Spinelli C, et al
    Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus.
    Ann Surg. 2023;278:e43-e50.
    PubMed     Abstract available


    June 2023
  12. GUJJURI RR, Clarke JM, Elliott JA, Rahman SA, et al
    Predicting long-term survival and time-to-recurrence after esophagectomy in patients with esophageal cancer - Development and validation of a multivariate prediction model.
    Ann Surg. 2023;277:971-978.
    PubMed    



  13. Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study: Erratum.
    Ann Surg. 2023;277:e1397.
    PubMed    


    May 2023
  14. BOERNER T, Harrington C, Tan KS, Adusumilli PS, et al
    Waiting to Operate: The Risk of Salvage Esophagectomy.
    Ann Surg. 2023;277:781-788.
    PubMed     Abstract available


  15. YAN L, Liu Y, Li W, Zhu Y, et al
    Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
    Ann Surg. 2023;277:846-853.
    PubMed     Abstract available


  16. BAYLEY EM, Ivy ML, Shewale JB, Ge PS, et al
    High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.
    Ann Surg. 2023;277:721-726.
    PubMed     Abstract available



  17. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).
    Ann Surg. 2023;277:e1026-e1034.
    PubMed     Abstract available


    April 2023
  18. KALFF MC, van Berge Henegouwen MI, Baas PC, Bahadoer RR, et al
    Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care: The Dutch Nationwide Ivory Study.
    Ann Surg. 2023;277:619-628.
    PubMed     Abstract available


    March 2023
  19. REZA JA, Raman V, Vekstein A, Grau-Sepulveda M, et al
    Implementation of Screening Guidelines in Early Esophageal Cancer: A Study of the Society of Thoracic Surgeons General Thoracic Surgery Database.
    Ann Surg. 2023 Mar 13. doi: 10.1097/SLA.0000000000005837.
    PubMed     Abstract available


  20. SACHIDANANDA S, Timsina L, Namburi N, Birdas TJ, et al
    Esophagectomy Complications Impact Long-term Survival: A National Cancer Database Analysis.
    Ann Surg. 2023;277:437-441.
    PubMed     Abstract available


    February 2023
  21. ELY S, Alabaster A, Dominguez DA, Maxim C, et al
    Effect of Thoracic Surgery Regionalization on 1- and 3-Year Survival after Cancer Esophagectomy.
    Ann Surg. 2023;277:e305-e312.
    PubMed     Abstract available


  22. RAHMAN SA, Walker RC, Maynard N, Nigel Trudgill, et al
    The AUGIS Survival Predictor: Prediction of Long-Term and Conditional Survival After Esophagectomy Using Random Survival Forests.
    Ann Surg. 2023;277:267-274.
    PubMed     Abstract available


  23. GUO X, Wang Z, Yang H, Mao T, et al
    Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2023;277:259-266.
    PubMed     Abstract available


    January 2023
  24. GRAY KD, Nobel TB, Hsu M, Tan KS, et al
    Improved Preoperative Risk Assessment Tools Are Needed to Guide Informed Decision Making before Esophagectomy.
    Ann Surg. 2023;277:116-120.
    PubMed     Abstract available


    December 2022
  25. ZHANG Y, Dong D, Cao Y, Huang M, et al
    Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Meta-analysis.
    Ann Surg. 2022 Dec 20. doi: 10.1097/SLA.0000000000005782.
    PubMed     Abstract available


  26. CARBONI F, Valle M
    Comment on: "Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short-And Long-term Outcomes From the Dutch Upper GI Cancer Audit".
    Ann Surg. 2022;276:e1121.
    PubMed    


  27. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Lindblad M, et al
    Long-term Survival in Esophageal Cancer After Minimally Invasive Esophagectomy Compared to Open Esophagectomy.
    Ann Surg. 2022;276:e744-e748.
    PubMed     Abstract available


  28. KALFF MC, Fransen LFC, de Groot EM, Gisbertz SS, et al
    Long-term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-score Matched Analysis.
    Ann Surg. 2022;276:e749-e757.
    PubMed     Abstract available


  29. SIHAG S, Nobel T, Hsu M, De La Torre S, et al
    Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
    Ann Surg. 2022;276:1017-1022.
    PubMed     Abstract available


  30. JEZERSKYTE E, Mertens AC, Dieren SV, Eshuis WJ, et al
    Gastrectomy Versus Esophagectomy for Gastroesophageal Junction Tumors: Short- and Long-Term Outcomes From the Dutch Upper Gastrointestinal Cancer Audit.
    Ann Surg. 2022;276:e735-e743.
    PubMed     Abstract available


    November 2022
  31. DONLON NE, Moran B, Kamilli A, Davern M, et al
    CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.
    Ann Surg. 2022;276:792-798.
    PubMed     Abstract available


  32. PERA M, Gibert J, Gimeno M, Garsot E, et al
    Machine Learning Risk Prediction Model of 90-day Mortality After Gastrectomy for Cancer.
    Ann Surg. 2022;276:776-783.
    PubMed     Abstract available


  33. COOLS-LARTIGUE J, Markar S, Mueller C, Hofstetter W, et al
    An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:799-805.
    PubMed     Abstract available


  34. WANG S, Huang S, Gao Z, Zhuang W, et al
    Comment on: The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-Negative Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:e645.
    PubMed    


  35. OKAMURA A, Yamamoto H, Watanabe M, Miyata H, et al
    Association Between Preoperative HbA1c Levels and Complications after Esophagectomy: Analysis of 15,801 Esophagectomies From the National Clinical Database in Japan.
    Ann Surg. 2022;276:e393-e399.
    PubMed     Abstract available


  36. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia After Esophageal Cancer Surgery: A Spectrum of Lung Injury Rather Than a Simple Infective Complication?
    Ann Surg. 2022;276:e400-e406.
    PubMed     Abstract available


  37. KINGMA BF, Grimminger PP, van der Sluis PC, van Det MJ, et al
    Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE): Results From the Multicenter International Registry.
    Ann Surg. 2022;276:e386-e392.
    PubMed     Abstract available


    October 2022
  38. MATSUDA S, Kitagawa Y, Okui J, Okamura A, et al
    Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 Oct 29. doi: 10.1097/SLA.0000000000005701.
    PubMed     Abstract available


  39. KANDIL E, Omar M, Aboueisha M, Attia AS, et al
    Efficacy and Safety of Radiofrequency Ablation of Thyroid Nodules: A Multi-institutional Prospective Cohort Study.
    Ann Surg. 2022;276:589-596.
    PubMed     Abstract available


    August 2022
  40. RHODIN KE, Raman V, Jensen CW, Kang L, et al
    The Effect of Center Esophagectomy Volume on Outcomes in Clinical Stage I-III Esophageal Cancer.
    Ann Surg. 2022 Aug 30. pii: 00000658-990000000-00247.
    PubMed     Abstract available


  41. RAJA S, Rice TW, Lu M, Semple ME, et al
    Adjuvant Therapy after Neoadjuvant Therapy for Esophageal Cancer: Who Needs It?
    Ann Surg. 2022 Aug 23. pii: 00000658-990000000-00237.
    PubMed     Abstract available


  42. CHANDRA R, Reznik SI
    Vacutainers and Primers Over X-Rays and Gamma Rays: The Role of Circulating Tumor DNA in Esophageal Adenocarcinoma Staging and Surveillance: Invited Commentary on "Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Aden
    Ann Surg. 2022;276:e127-e128.
    PubMed    


  43. CABALAG CS, Yates M, Corrales MB, Yeh P, et al
    Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:e120-e126.
    PubMed     Abstract available


  44. SIHAG S, Nobel T, Hsu M, Tan KS, et al
    A More Extensive Lymphadenectomy Enhances Survival After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Adenocarcinoma.
    Ann Surg. 2022;276:312-317.
    PubMed     Abstract available


  45. YANES M, Santoni G, Maret-Ouda J, Ness-Jensen E, et al
    Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries.
    Ann Surg. 2022;276:e79-e85.
    PubMed     Abstract available


    July 2022
  46. KALFF MC, Henckens SPG, Voeten DM, Heineman DJ, et al
    Recurrent Disease after Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study.
    Ann Surg. 2022 Jul 26. pii: 00000658-990000000-00187.
    PubMed     Abstract available


  47. WONG IYH, Chung JCY, Zhang RQ, Gao X, et al
    A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) with Lymph Node Status (ypN-category) Results in Better Prognostication than ypTNM Stage Groups after Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00184.
    PubMed     Abstract available


  48. MATSUDA S, Kitagawa Y, Takemura R, Okui J, et al
    Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score matched Analysis From 85 Authorized Institutes for Esophageal Cancer in Japan.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00138.
    PubMed     Abstract available


  49. HIRANO Y, Konishi T, Kaneko H, Itoh H, et al
    Impact of Prophylactic Corticosteroid Use on In-hospital Mortality and Respiratory Failure after Esophagectomy for Esophageal Cancer: Nationwide Inpatient Data Study in Japan.
    Ann Surg. 2022 Jul 14. pii: 00000658-990000000-00106.
    PubMed     Abstract available


  50. JUNTTILA A, Helminen O, Helmio M, Huhta H, et al
    Five-year Survival after McKeown Compared to Ivor-Lewis Esophagectomy for Esophageal Cancer: A Population-based Nationwide Study in Finland.
    Ann Surg. 2022 Jul 12. pii: 00000658-990000000-00103.
    PubMed     Abstract available


  51. ZHANG Y, Cao Y, Zhang J, Huang M, et al
    Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00063.
    PubMed     Abstract available


  52. JOGIAT UM, Sasewich H, Turner SR, Baracos V, et al
    Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00081.
    PubMed     Abstract available


  53. HOSOI T, Abe T, Higaki E, Fujieda H, et al
    Circular Stapled Technique Versus Modified Collard Technique for Cervical Esophagogastric Anastomosis After Esophagectomy: A Randomized Controlled Trial.
    Ann Surg. 2022;276:30-37.
    PubMed     Abstract available


  54. MOTOYAMA S, Maeda E, Iijima K, Sato Y, et al
    Does Esophagectomy Provide a Survival Advantage to Patients Aged 80 Years or Older? Analyzing 5066 Patients in the National Database of Hospital-based Cancer Registries in Japan.
    Ann Surg. 2022;276:e16-e23.
    PubMed     Abstract available


  55. POINTER DT JR, Saeed S, Naffouje SA, Mehta R, et al
    Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis.
    Ann Surg. 2022;276:111-118.
    PubMed     Abstract available


  56. HUGHES DT, Reyes-Gastelum D, Ward KC, Hamilton AS, et al
    Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.
    Ann Surg. 2022;276:e40-e47.
    PubMed     Abstract available


    May 2022
  57. OKUNO K, Tokunaga M, Kinugasa Y, Baba H, et al
    A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 May 13. pii: 00000658-990000000-00001.
    PubMed     Abstract available


  58. CLAASSEN L, Hannink G, Luyer MDP, Ainsworth AP, et al
    Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study.
    Ann Surg. 2022;275:911-918.
    PubMed     Abstract available


  59. FRANSEN LFC, Janssen THJB, Aarnoudse M, Nieuwenhuijzen GAP, et al
    Direct Oral Feeding After a Minimally Invasive Esophagectomy: A Single-Center Prospective Cohort Study.
    Ann Surg. 2022;275:919-923.
    PubMed     Abstract available


    April 2022
  60. SHEN Y, Zhang Y, He M, Fang Y, et al
    Advancing Gastroscope From Intraluminal to Extraluminal Dissection: Primary Experience of Laparo-gastroscopic Esophagectomy.
    Ann Surg. 2022;275:e659-e663.
    PubMed     Abstract available


  61. SUH YS, Na D, Lee JS, Chae J, et al
    Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
    Ann Surg. 2022;275:706-717.
    PubMed     Abstract available


  62. KAMARAJAH SK, Phillips AW, Hanna GB, Low DE, et al
    Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma?: A Propensity-matched Analysis.
    Ann Surg. 2022;275:700-705.
    PubMed     Abstract available


    March 2022
  63. KUPPUSAMY MK, Low DE
    Evaluation of International Contemporary Operative Outcomes and Management Trends Associated With Esophagectomy: A 4-Year Study of >6000 Patients Using ECCG Definitions and the Online Esodata Database.
    Ann Surg. 2022;275:515-525.
    PubMed     Abstract available


  64. RAMAN V, Jawitz OK, Farrow NE, Voigt SL, et al
    The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.
    Ann Surg. 2022;275:e562-e567.
    PubMed     Abstract available


    February 2022
  65. LI S, Ai Q, Liang H, Liu H, et al
    Nonintubated Robotic-assisted Thoracic Surgery for Tracheal/Airway Resection and Reconstruction: Technique Description and Preliminary Results.
    Ann Surg. 2022;275:e534-e536.
    PubMed     Abstract available


  66. MARKAR SR, Zaninotto G, Castoro C, Johar A, et al
    Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study.
    Ann Surg. 2022;275:e392-e400.
    PubMed     Abstract available


  67. RUCKER AJ, Raman V, Jawitz OK, Voigt SL, et al
    The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.
    Ann Surg. 2022;275:348-355.
    PubMed     Abstract available


    January 2022
  68. ELLIOTT JA, Markar SR, Klevebro F, Johar A, et al
    An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE).
    Ann Surg. 2022 Jan 27. pii: 00000658-900000000-93088.
    PubMed     Abstract available


  69. SANABRIA A, Betancourt C, Sanchez JG, Garcia C, et al
    Prophylactic Central Neck Lymph Node Dissection in Low-Risk Thyroid Carcinoma Patients Does not Decrease the Incidence of Locoregional Recurrence: A Meta-Analysis of Randomized Trials.
    Ann Surg. 2022 Jan 24. pii: 00000658-900000000-93112.
    PubMed     Abstract available


  70. BOSHIER PR, Klevebro F, Savva KV, Waller A, et al
    Assessment of Health Related Quality of Life and Digestive Symptoms in Long-term, Disease Free Survivors After Esophagectomy.
    Ann Surg. 2022;275:e140-e147.
    PubMed     Abstract available


  71. HARRIS A, Butterworth J, Boshier PR, MacKenzie H, et al
    Development of a Reliable Surgical Quality Assurance System for 2-stage Esophagectomy in Randomized Controlled Trials.
    Ann Surg. 2022;275:121-130.
    PubMed     Abstract available


    December 2021
  72. OSHIKIRI T, Numasaki H, Oguma J, Toh Y, et al
    Prognosis of Patients with Esophageal Carcinoma following Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93155.
    PubMed     Abstract available


  73. CLAASSEN L, Hannink G, van Workum F, Rosman C, et al
    Response to the Comment on "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics a Retrospective Multi-national Cohort Study".
    Ann Surg. 2021;274:e930.
    PubMed    


  74. PRASAD P, Phillips AW
    Comment on "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study".
    Ann Surg. 2021;274:e929-e930.
    PubMed    


  75. HOLSCHER AH, Bollschweiler E
    Comment on "Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma? A Propensity-matched Analysis".
    Ann Surg. 2021;274:e916-e917.
    PubMed    


  76. NABHAN FA
    Comment on "Barriers to the Use of Active Surveillance for Thyroid Cancer: Results of a Physicians Survey".
    Ann Surg. 2021;274:e880-e881.
    PubMed    


  77. SHEN H, Liu Q
    Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e805-e806.
    PubMed    


  78. LU J, Wu D, Huang C
    Comment on "The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e845-e846.
    PubMed    


  79. RAJA S, Blackstone EH
    Response to the Comments on "Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e757-e758.
    PubMed    


  80. KUROKAWA Y, Doki Y, Takeuchi H, Kitagawa Y, et al
    Response to the Comment on: Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors.
    Ann Surg. 2021;274:e806-e807.
    PubMed    


  81. FRANSEN LFC, Luyer MDP
    Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e741-e742.
    PubMed    


  82. ZHANG G, Zhang H, Li Q, Li J, et al
    Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e740-e741.
    PubMed    


  83. KHAW RA, Kamarajah SK, Phillips AW
    Comments on "Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e756-e757.
    PubMed    


  84. MORIS D, Tsilimigras DI, Schizas D
    Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e744-e745.
    PubMed    


  85. FRANSEN LFC, Luyer MDP
    Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e745-e746.
    PubMed    


  86. KUROKAWA Y, Takeuchi H, Doki Y, Kitagawa Y, et al
    Response to the Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e682-e683.
    PubMed    


  87. ZHAO B, Liang R, Li G
    Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e681-e682.
    PubMed    


  88. VAN DER WILK BJ, van Lanschot JJB
    Response to the Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2021;274:e697-e698.
    PubMed    


  89. GUTSCHOW CA
    Response to the Comment on "Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database".
    Ann Surg. 2021;274:e686.
    PubMed    


  90. MOLENA D, Louie BE, Demeester SR
    Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2021;274:e695-e696.
    PubMed    


  91. KAMARAJAH SK, Griffiths EA
    Comment on "Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database".
    Ann Surg. 2021;274:e685-e686.
    PubMed    


  92. YONEKURA H, Nakamori Y, Takeda C, Kawasaki Y, et al
    Comment on "The Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2021;274:e672.
    PubMed    


  93. FRANSEN LFC, Berkelmans GHK, Asti E, Henegouwen MIVB, et al
    The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study.
    Ann Surg. 2021;274:e1129-e1137.
    PubMed     Abstract available


  94. SAKAMOTO T, Fujiogi M, Yasunaga H
    Response to the Comment on "Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2021;274:e672-e673.
    PubMed    


  95. LENG X, He W, Yang H, Chen Y, et al
    Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2021;274:e1022-e1029.
    PubMed     Abstract available


  96. MARET-OUDA J, Santoni G, Wahlin K, Artama M, et al
    Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
    Ann Surg. 2021;274:e535-e540.
    PubMed     Abstract available


  97. SCHOPPMANN SF, Jomrich G
    Response to the Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Ann Surg. 2021;274:e669-e670.
    PubMed    


  98. SUN L, Liang H, Feng Y
    Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Ann Surg. 2021;274:e668-e669.
    PubMed    


  99. VAN DER WILK BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, et al
    Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
    Ann Surg. 2021;274:1009-1016.
    PubMed     Abstract available


    November 2021
  100. HIRANO Y, Kaneko H, Konishi T, Itoh H, et al
    Impact of Body Mass Index on Major Complications, Multiple Complications, In-hospital Mortality, and Failure to Rescue Following Esophagectomy for Esophageal Cancer: A Nationwide Inpatient Database Study in Japan.
    Ann Surg. 2021 Nov 23. pii: 00000658-900000000-93169.
    PubMed     Abstract available


  101. LIU F, Yang W, Yang W, Xu R, et al
    Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer from a Real-World Multicenter Study.
    Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93196.
    PubMed     Abstract available


  102. HE Z, Liu F, Yang W, Ke Y, et al
    Response to: Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".
    Ann Surg. 2021 Nov 9. pii: 00000658-900000000-93201.
    PubMed    


  103. HUANG S, Wang S, Gao Z, Qiao G, et al
    Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".
    Ann Surg. 2021 Nov 9. pii: 00000658-900000000-93198.
    PubMed    


  104. KALFF MC, Gottlieb-Vedi E, Verhoeven RHA, van Laarhoven HWM, et al
    Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands.
    Ann Surg. 2021;274:743-750.
    PubMed     Abstract available


  105. HERTAULT H, Gandon A, Behal H, Legault G, et al
    Incidence and Risk Factors for Diaphragmatic Herniation Following Esophagectomy for Cancer.
    Ann Surg. 2021;274:758-765.
    PubMed     Abstract available


  106. MULLER PC, Morell B, Vetter D, Raptis DA, et al
    Preemptive Endoluminal Vacuum Therapy to Reduce Morbidity After Minimally Invasive Ivor Lewis Esophagectomy: Including a Novel Grading System for Postoperative Endoscopic Assessment of GI-Anastomoses.
    Ann Surg. 2021;274:751-757.
    PubMed     Abstract available


  107. DONLON NE, Kammili A, Roopnarinesingh R, Davern M, et al
    FLOT-regimen Chemotherapy and Transthoracic en bloc Resection for Esophageal and Junctional Adenocarcinoma.
    Ann Surg. 2021;274:814-820.
    PubMed     Abstract available


  108. WONG IYH, Zhang RQ, Tsang RKY, Kwok JYY, et al
    Improving Outcome of Superior Mediastinal Lymph Node Dissection During Esophagectomy: A Novel Approach Combining Continuous and Intermittent Recurrent Laryngeal Nerve Monitoring.
    Ann Surg. 2021;274:736-742.
    PubMed     Abstract available


    October 2021
  109. RAJA S, Rice TW, Murthy SC, Ahmad U, et al
    Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma.
    Ann Surg. 2021;274:e320-e327.
    PubMed     Abstract available


    September 2021
  110. LEE Y, Samarasinghe Y, Lee MH, Thiru L, et al
    Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis.
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93257.
    PubMed     Abstract available


  111. KLOFT M, Ruisch JE, Raghuram G, Emmerson J, et al
    Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial.
    Ann Surg. 2021 Sep 13. pii: 00000658-900000000-93281.
    PubMed     Abstract available


  112. VOETEN DM, Gisbertz SS, Ruurda JP, Wilschut JA, et al
    Overall Volume Trends in Esophageal Cancer Surgery Results From the Dutch Upper Gastrointestinal Cancer Audit.
    Ann Surg. 2021;274:449-458.
    PubMed     Abstract available


  113. KAMEL MK, Harrison S, Lee B, Port JL, et al
    Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity Matched Analysis of the National Cancer Database.
    Ann Surg. 2021 Sep 1. pii: 00000658-900000000-93285.
    PubMed     Abstract available


  114. LIMBERG J, Ullmann TM, Stefanova D, Buicko JL, et al
    Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer?: A National Cancer Database Analysis.
    Ann Surg. 2021;274:e276-e281.
    PubMed     Abstract available


  115. CLARK JM, Cooke DT, Hashimi H, Chin D, et al
    Do the 2018 Leapfrog Group Minimal Hospital and Surgeon Volume Thresholds for Esophagectomy Favor Specific Patient Demographics?
    Ann Surg. 2021;274:e220-e229.
    PubMed     Abstract available


    August 2021
  116. FRANSEN LFC, Luyer MDP
    Response to the Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial) an International, Multicenter, Open-label Randomized Controlled Trial".
    Ann Surg. 2021;274:e196-e197.
    PubMed    


  117. MORIS D, Cerullo M
    Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial".
    Ann Surg. 2021;274:e196.
    PubMed    


  118. SAKAMOTO T, Fujiogi M, Matsui H, Fushimi K, et al
    Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis.
    Ann Surg. 2021;274:324-330.
    PubMed     Abstract available


    July 2021
  119. NOMA T, Makino T, Ohshima K, Sugimura K, et al
    Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93382.
    PubMed     Abstract available


  120. DEFIZE IL, Goense L, Borggreve AS, Mook S, et al
    Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results from the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93365.
    PubMed     Abstract available


  121. VOETEN DM, Busweiler LAD, van der Werf LR, Wijnhoven BPL, et al
    Outcomes of Esophagogastric Cancer Surgery during eight Years of Surgical Auditing by the Dutch Upper Gastrointestinal Cancer Audit (DUCA).
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93364.
    PubMed     Abstract available


  122. DEMEESTER SR
    Response to the Comment on "The Prevalence of Lymph Node Metastases in Patients With T1 Esophageal Adenocarcinoma A Retrospective Review of Esophagectomy Specimens".
    Ann Surg. 2021;274:e106-e107.
    PubMed    


  123. KUROKAWA Y, Takeuchi H, Doki Y, Mine S, et al
    Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
    Ann Surg. 2021;274:120-127.
    PubMed     Abstract available


    June 2021
  124. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Hedberg J, et al
    Extent of Lymphadenectomy and Long-Term Survival in Esophageal Cancer.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93462.
    PubMed     Abstract available


  125. YANG Y, Li B, Yi J, Hua R, et al
    Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial.
    Ann Surg. 2021 Jun 18. pii: 00000658-900000000-93478.
    PubMed     Abstract available


  126. WANG BY, Lin CH, Wu SC, Chen HS, et al
    Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2021 Jun 10. pii: 00000658-900000000-93505.
    PubMed     Abstract available


  127. YANG W, Liu F, Xu R, Yang W, et al
    Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data.
    Ann Surg. 2021 Jun 2. pii: 00000658-900000000-93529.
    PubMed     Abstract available


  128. KELLY RJ, Ansari AM, Miyashita T, Zahurak M, et al
    Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
    Ann Surg. 2021;273:e206-e213.
    PubMed     Abstract available


    May 2021
  129. DU J, Shen X
    Comment on "Genomic Alteration and Immunity-Implications In Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93540.
    PubMed    


  130. DU J, Guan W, Shen X
    Comment on "Circulating Tumor Cells-New Indicator For Clinical Staging Of Patients With Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93536.
    PubMed    


  131. KOSUMI K, Baba Y, Baba H
    Response to Comment on "Genomic Alteration and Immunity-Implications in Esophageal Cancer".
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93548.
    PubMed    


  132. REEH M
    Response to Comment on "Circulating Tumor Cells - New Indicator for Clinical Staging of Patients with Esophageal Cancer" by Wenxian Guan.
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93547.
    PubMed    


  133. VAN DER WILK BJ, Eyck BM, Hofstetter WL, Ajani JA, et al
    Chemoradiotherapy followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis.
    Ann Surg. 2021 May 11. doi: 10.1097/SLA.0000000000004930.
    PubMed     Abstract available


  134. XIE SH, Santoni G, Malberg K, Lagergren P, et al
    Prediction Model of Long-term Survival After Esophageal Cancer Surgery.
    Ann Surg. 2021;273:933-939.
    PubMed     Abstract available


    April 2021
  135. HARADA K, Hwang H, Wang X, Abdelhakeem A, et al
    Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.
    Ann Surg. 2021;273:751-757.
    PubMed     Abstract available


  136. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a Simple Infective Complication? (ANNSURG-D21-00007).
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004873.
    PubMed    


  137. BABA Y, Kosumi K, Baba H
    Comments on "The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?"
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004879.
    PubMed    


    March 2021
  138. LEVY J, Gupta V, Coburn NG
    Response to "Comment on Textbook Outcome and Survival in Patients with Gastric Cancer: An Analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO)".
    Ann Surg. 2021 Mar 5. pii: 00000658-900000000-93662.
    PubMed    


  139. JAWITZ NG, Raman V, Jawitz OK, Shimpi RA, et al
    Utilization Trends and Volume-Outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer.
    Ann Surg. 2021 Mar 3. doi: 10.1097/SLA.0000000000004834.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.